The American College of Obstetricians and Gynecologists (ACOG) issued new guidance on October 15 that strongly recommends hormone therapy for many women with common menopause symptoms. The update follows similar recommendations from the American College of Physicians and reflects a broader shift in how medical organizations approach menopause care.
What the New Guidance Recommends
ACOG now considers hormone therapy a first-line treatment for hot flashes, night sweats, and the sleep problems that often accompany them. Its “strong” designation means the organization believes the benefits clearly outweigh the harms for most patients with these symptoms, as reported by The New York Times.
The guidance generally favors starting treatment before age 60 or within 10 years of menopause. It also recognizes that some women already taking hormones may need to continue past 60 to manage persistent symptoms.
That is a notable change in approach. ACOG’s 2014 guidance supported hormone therapy but encouraged the lowest effective dose for the shortest possible time. The new recommendations still call for regular review, but they give more weight to individual decisions than to fixed limits.
Why the Shift Matters
These symptoms are widespread. Hot flashes and night sweats affect up to 80% of women going through menopause, according to the American College of Physicians.
Hormone therapy use dropped sharply in the early 2000s after the Women’s Health Initiative found that some forms carried a small increased risk of breast cancer and cardiovascular problems. Prescriptions have risen in recent years, but only a small minority of women use it today.
Reversals in medical guidance can affect patient confidence for years, a pattern also visible as public trust in vaccines comes under strain.
Who May Not Be a Good Candidate
Hormone therapy is not appropriate for everyone. ACOG recommends that doctors weigh age and medical history before prescribing it:
- A history of blood clots, stroke, or certain cancers generally rules out hormone therapy.
- Women at high risk for breast cancer or heart disease may not be suitable candidates.
- Cardiovascular risk can be assessed with the American College of Cardiology’s calculator.
- Breast cancer risk can be assessed with the National Cancer Institute’s tool.
Cardiovascular risk itself depends on many factors, including blood pressure, family history, and diet, particularly regular consumption of ultra-processed foods.
The guidance does not set specific thresholds for when risk results should rule out treatment, a gap some physicians have pointed out. Formulation also matters. Skin patches may carry less clot risk than pills for some women.
Options for Women Who Cannot Take Hormones
For patients who cannot or prefer not to use hormones, ACOG recommends two alternatives. One is a newer class of drugs that block certain receptors in the brain. The other is a group of antidepressants that can reduce hot flashes and night sweats.
Cognitive behavioral therapy may help with some symptoms, although the evidence is limited. Access can be difficult as well, since cost, scheduling, and transportation to appointments can make regular sessions hard to maintain.
Limiting caffeine and alcohol may reduce hot flashes for some women. Alcohol’s broader health risks are also the subject of proposed alcohol labeling rules.
What the Guidance Does Not Cover
The recommendations address hot flashes, night sweats, related sleep problems, and mood changes. ACOG found the evidence for using hormone therapy to treat mood changes insufficient. Separate guidance on genitourinary syndrome of menopause, which includes vaginal dryness and urinary tract infections, is expected next year.
The guidance also does not recommend hormone therapy for women without symptoms as a way to prevent heart disease or cognitive decline. That practice was common before 2002, and current research on cardiovascular disease prevention focuses on other approaches.
ACOG’s upcoming recommendations will add to ongoing health news about women’s midlife care.
Information Inside Road covers changes in women’s health guidance as they develop. Women experiencing menopause symptoms should review these recommendations with their doctor to determine which treatment fits their health history.